Iridex (IRIX) Cash from Operations Growth (1y) (2012 - 2026)
Powered by 
Analysis
Iridex (IRIX) Cash from Operations Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | -12.60% |
| 10 | Iridex | 12.22 Mn | 7.54 Mn | 4.30 Mn | 143.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 4, 2026 | 143.83% |
| Apr 4, 2026 | -16.19% |
| Jan 3, 2026 | 147.58% |
| Sep 27, 2025 | 62.32% |
| Jun 28, 2025 | 70.06% |
| Mar 29, 2025 | 30.28% |
| Dec 28, 2024 | -26.46% |
| Sep 28, 2024 | -72.45% |
| Jun 29, 2024 | -16.21% |
| Mar 30, 2024 | 42.03% |
| Dec 30, 2023 | 38.43% |
| Sep 30, 2023 | 15.38% |
| Jul 1, 2023 | 55.60% |
| Apr 1, 2023 | 12.60% |
| Dec 31, 2022 | -114.14% |
| Apr 2, 2022 | -127.50% |
| Apr 3, 2021 | 914.18% |
| Sep 26, 2020 | 116.00% |
| Jun 27, 2020 | -45.60% |
| Mar 28, 2020 | 61.73% |